Afyren
FranceWho owns Afyren?
Afyren is a French Biotech company, currently owned by Odyssée Venture since 2026 and Sofinnova Partners. It changed hands in 2021, when Supernova Invest sold.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
Ownership history
3 ownership periods · co-invest detected
Supernova Invest took Afyren public via IPO in 2021 after 4 years.
More from Sofinnova Industrial Biotech
Other portfolio companies in the same fund.
United States
Spain
NetherlandsMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns Afyren?
Afyren is currently owned by Odyssée Venture and Sofinnova Partners, through Sofinnova Industrial Biotech, since 2026.
When did Odyssée Venture and 1 other acquire Afyren?
Odyssée Venture and 1 other acquired Afyren in 2026.
Who has owned Afyren over time?
Afyren has been through 3 private-equity ownership periods: Supernova Invest · via Supernova 2 · 2017–2021 · (IPO); Sofinnova Partners · via Sofinnova Industrial Biotech · since 2019; Odyssée Venture · via Odyssee Venture Funds · since 2026.